Drug Cartel: Pfizer scores record profits via taxpayer funnel, on track for $100 billion in 2022 revenue

Most of Pfizer's revenue comes via taxpayers subsidizing their junk products.

The criminals and quacks who run Pfizer are getting filthy rich through the sale of their mRNA injection to governments, which, since 2020, have used taxpayer funds to place endless purchase orders for what was once described as a cure to the novel coronavirus, but is now quite clearly a failed product.

Barron's @barronsonline

Pfizer posted a sharp rise in revenue for the first quarter, thanks largely to its Covid-19 vaccine.

on.barrons.comPfizer Earnings and Revenue Soundly Beat EstimatesPfizer posted a sharp rise in revenue for the first quarter, thanks largely to its Covid-19 vaccine.

In a stunning earnings report published Tuesday, Pfizer announced they had logged $26 billion in Q1 sales, marking a quarterly profit of $7.86 billion. Revenue went up 77% while profit was up 61%. The company is on track to bring in over $100 billion in revenue and $32 billion in net income this year, and the vast majority of cash is coming from the American taxpayer and other government “customers” via their taxpayers, who have virtually no say in the matter.

king Keith @KaConfessor

Pfizer just posted a profit of $7.86 billion in Quarter 1. That's not revenue. That's PROFIT. It seems like the only thing being boosted is revenue.

cnbc.comPfizer cuts 2022 earnings outlook despite strong first-quarter Covid vaccine and antiviral salesPfizer said it sold $13.2 billion of its Covid vaccine and $1.5 billion of its antiviral treatment Paxlovid.

More than half of their revenue ($13.2 billion) came from sales of their COVID “vaccine,” which has produced no actual demand in a consumer market. Another $1.5 billion came in sales of its oral COVID treatment Paxlovid, another product that is being financed entirely by governments.

New York Post @nypost

Pfizer Q1 profit, revenue soar on COVID-19 vaccine sales trib.al/PsM3bsQ

It’s an impressive haul for a company that made most of its money off of a once-claimed immunizing “vaccine” — the mRNA COVID shot — that doesn’t currently work. Most countries are now on shot 4 of the Pfizer “miracle cure.”

The mRNA injection, branded as Comirnaty, has never been reformulated. It was designed in January of 2020 for an early strain that was reported out of Wuhan, China. That strain has not been identified in any human beings for about two years.

Albert Bourla @AlbertBourla

Excited to share that updated analysis from our Phase 3 study with BioNTech also showed that our COVID-19 vaccine was 100% effective in preventing #COVID19 cases in South Africa. 100%!

pfizer.comPfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline …Analysis of 927 confirmed symptomatic cases of COVID-19 demonstrates BNT162b2 is highly effective with 91.3% vaccine efficacy observed against COVID-19, measured seven days through up to six months after the second dose Vaccine was 100% effective in preventing severe disease as defined by the U.S. C…

In order to keep profits soaring and expand its “customer” base, Pfizer is currently seeking authorization for three doses of its failed, expired vaccine for children under 5 years old, who are not statistically threatened by COVID-19.

Moderna, the upstart government-subsidized drug cartel rival to Pfizer, is set to report its Q1 revenue numbers Wednesday.

The Pharma Cartel: America's COVID-19 vaccine market remains closed off to outside competition

The U.S. COVID-19 vaccine market remains completely shut off to outside competition, despite there being no evidence of superior “vaccine” products in the United States through the two mRNA shots. This allowed the likes of Pfizer and Moderna to become the only game in town (J&J exited the market), effectively operating in concert with the government as a mutually-beneficial drug cartel. And the profits speak for themselves.